BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

RedHill Biopharma Ltd. 

21 Ha’arba’a Street

Tel-Aviv    64739  Israel
Phone: 972-0-3-541-3131 Fax: 972-0-3-541-3144


SEARCH JOBS




Industry
Pharmaceutical






 Company News
RedHill Biopharma Ltd. (RDHL) Acquires Technology From University of Minnesota As Part Of Ongoing RHB-104 Phase 3 Crohn's Program 12/18/2014 7:36:05 AM
RedHill Biopharma Ltd. (RDHL) Announces First Patients Enrolled In The Phase 3 Study Of RHB-102 (BEKINDA(TM)) For Gastroenteritis And Gastritis 12/17/2014 7:25:03 AM
RedHill Biopharma Ltd. (RDHL) Submits BEKINDA™ (RHB-102) European Marketing Authorization Application For Oncology Support 12/9/2014 10:39:03 AM
RedHill Biopharma Ltd. (RDHL)To Sponsor And Exhibit Its Ongoing Phase 3 Crohn's Program At The Israeli IBD Society Meeting 12/2/2014 11:53:40 AM
RedHill Biopharma Ltd. (RDHL) And IntelGenx Corp. Announce Acceptance For Review Of European Marketing Application For RIZAPORT For Migraines 12/1/2014 10:30:25 AM
RedHill Biopharma Ltd. (RDHL) Reports Results For The Third Quarter Of 2014 11/10/2014 7:51:48 AM
FDA Grants QIDP Fast-Track Designation To RedHill Biopharma Ltd. (RDHL)'s Phase 3 H. Pylori Drug RHB-105 11/10/2014 7:32:47 AM
RedHill Biopharma Ltd. (RDHL) To Host Third Quarter 2014 Financial Results Conference Call On November 10, 2014 10/28/2014 7:02:57 AM
RedHill Biopharma Ltd. (RDHL) To Present At The 20th Annual BIO-Europe International Partnering Conference 10/22/2014 7:30:24 AM
RedHill Biopharma Ltd. (RDHL) And IntelGenx Corp. Submit European Marketing Authorization Application For Migraine Drug RIZAPORT® (Formerly RHB-103) 10/1/2014 9:12:10 AM
123456789